Symposium Agenda Faculty Registration Exhibitors Accommodations Contact Home
 


This powerful and engaging four-day event in downtown Chicago is chaired by:

Symposium Chair
William J. Gradishar, MD

Symposium Co-Chair
V. Craig Jordan
OBE, PhD, DSc

Symposium Co-Chair
Monica Morrow, MD

 


Join us for future symposia!
October 28-31, 2010
September 15-18, 2011
October 4-7, 2012

2009 Program Description
An annual conference targeting individuals actively engaged clinically or scientifically in diagnostic and therapeutic radiology, oncology, surgery, gynecology, family practice and genetics.

The optimal management of breast cancer is rapidly evolving. A multidisciplinary team of medical, surgical and radiation oncologists, pathologists, plastic surgeons and genetic counselors are routinely involved in offering treatment recommendations for individual patients with a diagnosis of breast cancer. With the emergence of prevention strategies, women at high risk of developing breast cancer are now evaluated for medical therapies, surgical options and lifestyle changes that may reduce their risk of developing breast cancer. The 11th Annual Lynn Sage Breast Cancer Symposium provides a forum for discussing and presenting laboratory and clinical research concerning the care of patients with breast cancer.

2009 Educational Objectives
At the conclusion of this symposium participants should be able to:
1. Explain the importance of communication skills as a means of discussing recurrence risk and conveying bad news to patients.
2. Cite different variants of breast cancer and their associated clinical implications.
3. Identify the controversies surrounding the use of breast MRI for surgical management of early stage breast cancer.
4. Describe the evolving role of genomic profiling for management of early stage breast cancer.
5. Analyze treatment strategies for treating triple-negative breast.
6. Discuss the adjuvant radiation therapy options for women with early stage breast cancer.
7. Describe the optimal use of endocrine therapy in the adjuvant treatment of breast cancer.
8. Describe novel systemic therapy for the treatment of inflammatory and metastatic breast cancer.

 



 


Alternate Breast Imaging: What's Useful? What's Not

Unusual Cases #1

Unusual Cases #2